Adasuve Aerosol, Powder
Product Images NDC 51097-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Adasuve (NDC 51097-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alexza Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Adasuve 01)

FDA Label Image

Figure 2 (Adasuve 02)

FDA Label Image

Figure 3 (Adasuve 03)

FDA Label Image

Figure 4 (Adasuve 04)

FDA Label Image

Figure 5 (Adasuve 05)

FDA Label Image

Figure 6 (Adasuve 06)

FDA Label Image

Figure 7 (Adasuve 07)

FDA Label Image

Chemical Structure (Adasuve 08)

FDA Label Image

Figure 8 (Adasuve 09)

Figure 8 (Adasuve 09)
This appears to be a graph or table showing the Mean Plasma Loxapine Concentration and Wean Plasma Loxapine Concentration over time after dosing (in minutes) for the medication ADASUVE 10mg in a study with 8 participants. Without additional context, the purpose or significance of the data cannot be determined.*
FDA Label Image

Figure 9 (Adasuve 10)

FDA Label Image

Figure 10 (Adasuve 11)

Figure 10 (Adasuve 11)
This appears to be a graph or chart showing the mean change in PEC total score over time post-dose (in minutes) for a placebo group of 105 and a group of 105 who received ADASUVE 10mg. The change in score is negative for the placebo group.*
FDA Label Image

Adasuve-12 (Adasuve 12)

Adasuve-12 (Adasuve 12)
ADASUVE is a medication that should only be administered through oral inhalation, and it is not recommended for patients with symptoms of respiratory problems or those taking medications to treat these problems. This medication is provided in a single-use packaging, and it should be discarded after use. The manufacturer is Alexza Pharmaceuticals. For more detailed information, refer to the package insert. The medication should be stored between 15°C-30°C (59°F-86°F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.